0% found this document useful (0 votes)
3 views6 pages

PHARMACEUTICAL PRODUCT DEVELOPMENT-2mark

The document outlines various types of pharmaceutical containers, excipients, and optimization techniques used in drug formulation and development. It highlights the importance of quality by design (QbD) and the roles of different materials and methods in ensuring product stability, efficacy, and regulatory compliance. Additionally, it discusses the applications of optimization in pharmaceutical processes, emphasizing the benefits of improved product quality and efficiency.

Uploaded by

Ismail Ka
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
3 views6 pages

PHARMACEUTICAL PRODUCT DEVELOPMENT-2mark

The document outlines various types of pharmaceutical containers, excipients, and optimization techniques used in drug formulation and development. It highlights the importance of quality by design (QbD) and the roles of different materials and methods in ensuring product stability, efficacy, and regulatory compliance. Additionally, it discusses the applications of optimization in pharmaceutical processes, emphasizing the benefits of improved product quality and efficiency.

Uploaded by

Ismail Ka
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 6

1.

Types of glass containers – Type I (Borosilicate glass), Type II (Treated


soda-lime glass), Type III (Soda-lime glass), Type IV (General-purpose
glass).

2. Metal containers – Aluminum, Tin, Stainless steel.

3. Sorbitol – A sugar alcohol used as a sweetener and humectant in


pharmaceuticals.

4. Examples of semisolid excipients – Petrolatum, Lanolin, Waxes,


Polyethylene glycols.

5. Statistical design of optimization – Use of statistical techniques like


factorial design, response surface methodology (RSM) to optimize
formulations.

6. Advantages of quality by design (QbD) – Improved product quality,


reduced variability, regulatory flexibility, cost-effectiveness.

7. Water-soluble organic solvents – Ethanol, Propylene glycol, Glycerin,


Polyethylene glycol (PEG).

8. Numerical optimization techniques – Gradient descent, Genetic


algorithms, Simulated annealing, Newton-Raphson method.

9. Fractional factorial design – A subset of a full factorial design used to


reduce experimental runs while maintaining key interactions.

10. Pharmaceutical product development – Process of designing, testing,


and optimizing drug formulations for safety, efficacy, and regulatory
approval.

11. Evaluation test for granules – Bulk density, Tapped density, Angle of
repose, Moisture content, Particle size distribution, Flowability.
12. Objectives of pharmaceutical product development – Ensure drug stability,
Improve bioavailability, Enhance patient compliance, Achieve regulatory
approval.
13. Non-ionic surfactants – Surface-active agents that do not ionize in solution,
e.g., Polysorbates (Tween), Sorbitan esters (Span).
14. Gelling agents – Substances that increase viscosity and form gels, e.g.,
Carbopol, Xanthan gum, Hydroxypropyl methylcellulose (HPMC).
15. Coating materials – Substances used to coat tablets for protection, taste-
masking, and controlled release, e.g., Hydroxypropyl cellulose, Shellac,
Titanium dioxide.
16. Advantages of binders – Improve tablet hardness, Enhance compressibility,
Ensure uniform drug distribution, Reduce friability.
17. Multilevel and multiobjective optimization – Multilevel optimization
involves solving hierarchical problems, while multiobjective optimization
deals with optimizing multiple conflicting objectives simultaneously.
18. Factors and trials – Factors are independent variables affecting outcomes,
while trials are experimental runs conducted to study these factors.
19. Device packaging – The process of enclosing medical devices in sterile,
protective, and regulatory-compliant packaging.
20. Functions of pharmaceutical packaging – Protects drug stability, Ensures
patient safety, Provides dosage information, Enhances product identification.
21. Advantages of plastic containers – Lightweight, Cost-effective, Shatter-
resistant, Chemical resistance, Flexible designs.
22. Secondary packaging – Outer packaging that protects primary packaging,
e.g., cartons, boxes, shrink wraps.
23. Applications of surfactants and examples – Used as emulsifiers,
solubilizers, wetting agents, and detergents; examples: Polysorbates (Tween),
Sodium lauryl sulfate, Lecithin.
24. Suspending agents – Substances that prevent sedimentation of particles in
suspensions, e.g., Xanthan gum, Methylcellulose, Bentonite, Carbopol.
25. Types of variable optimization – Continuous, Discrete, Categorical, Mixed-
variable optimization.
26. Objectives of quality by design (QbD) – Improve product quality, Reduce
variability, Enhance process understanding, Ensure regulatory compliance.
27. Water-insoluble organic solvents – Ethyl acetate, Benzene, Chloroform,
Toluene.
28. Full factorial design – An experimental design where all possible
combinations of factors and levels are tested.
29. Pharmaceutical excipient - II – Includes categories like lubricants,
disintegrants, colorants, and preservatives used in formulations.
30. Classification of emulsifying agents – Natural (Acacia, Lecithin), Synthetic
(Tweens, Spans), Finely divided solids (Bentonite, Magnesium hydroxide),
Amphiphilic macromolecules (Gelatin, Casein).
31. Objectives of pharmaceutical product development – Ensure drug stability,
Improve bioavailability, Enhance patient compliance, Achieve regulatory
approval.
32. Stability indicating assay method – A validated analytical method used to
detect and quantify the active pharmaceutical ingredient (API) and its
degradation products under stress conditions.
33. Role of alcohol as solvents – Used as a co-solvent to dissolve poorly water-
soluble drugs, enhance drug absorption, and act as a preservative in
formulations.
34. Examples of suspending agents – Xanthan gum, Methylcellulose, Bentonite,
Carbopol.
35. Lubricants and sorbents – Lubricants reduce friction during tablet
compression (e.g., Magnesium stearate), while sorbents absorb moisture and
improve stability (e.g., Silica gel).
36. Anti-adherents – Agents that prevent tablet sticking to punches and dies
during compression, e.g., Talc, Magnesium stearate, Starch.
37. Confounding – A situation in experimental design where the effect of one
factor is mixed with another, making it difficult to distinguish their individual
impacts.
38. Optimization benefits for industry – Cost reduction, Improved product
quality, Increased efficiency, Better regulatory compliance.
39. Types of packaging – Primary (Direct contact with drug, e.g., Blister packs),
Secondary (Outer protection, e.g., Cartons), Tertiary (Bulk transport, e.g.,
Pallets).
40. Compliance – Adherence to regulations, guidelines, and prescribed drug
usage to ensure safety and efficacy in pharmaceuticals.
41. Types of packaging materials – Glass, Plastic, Metal, Paper, Rubber.
42. Advantages of metal containers – Durable, Protects from light and moisture,
Tamper-resistant, Recyclable.
43. Pre-formulation – The initial phase in drug development where physical,
chemical, and mechanical properties of a drug substance are studied to
optimize formulation.
44. Types of suspending agents – Natural (Acacia, Tragacanth), Synthetic
(Carbopol, Sodium carboxymethyl cellulose), Inorganic (Bentonite,
Magnesium hydroxide).
45. Examples of semisolid excipients – Petrolatum, Lanolin, Waxes,
Polyethylene glycols.
46. Evaluation test for closures – Seal integrity, Leak test, Compatibility test,
Torque test.
47. Directly compressible vehicles – Excipients that allow tablet compression
without granulation, e.g., Microcrystalline cellulose, Spray-dried lactose.
48. Capsule excipients – Fillers (Lactose, Starch), Lubricants (Magnesium
stearate), Disintegrants (Croscarmellose sodium), Surfactants (Sodium lauryl
sulfate).
49. Optimization – The process of improving formulation or process parameters
to achieve the best possible outcome in pharmaceutical development.
50. Directly compressible vehicles – Excipients used in tablet formulation that
enable direct compression without prior granulation.
51. Advantages of plastic containers – Lightweight, Cost-effective, Shatter-
resistant, Flexible, Resistant to chemicals.
52. Examples of non-ionic surfactants – Polysorbates (Tween 80), Sorbitan
esters (Span 60), Polyethylene glycol (PEG), Lecithin.
53. Excipients – Inactive substances used in drug formulations to aid processing,
stability, and drug delivery.
54. Types of solvents – Aqueous (Water, Ethanol), Organic (Chloroform,
Acetone), Semi-polar (Methanol, Isopropanol).
55. Uses of polyethylene glycol (PEG) – Solvent, Plasticizer, Lubricant,
Emulsifier, Base for ointments.
56. Benefits of quality by design (QbD) – Improved product quality, Reduced
variability, Cost-effectiveness, Regulatory flexibility.
57. Raw materials used for packaging – Glass, Plastic, Metal, Rubber,
Paperboard.
58. Aerosol – A pressurized dosage form that dispenses a fine mist or spray
containing active pharmaceutical ingredients.
59. Different types of tablet coating – Sugar coating, Film coating, Enteric
coating, Compression coating.
60. Optimization techniques – Methods used to improve formulation and
processes, e.g., Response Surface Methodology (RSM), Factorial Design,
Genetic Algorithms.
1. Advantages of Glass Containers

• Chemically inert and non-reactive with drugs.

• Provides excellent barrier properties against moisture and gases.

• Transparent, allowing easy inspection of the contents.

• Can withstand high temperatures and sterilization processes.

• Recyclable and environmentally friendly.

2. Tertiary Packaging

• Used for bulk transportation and storage of pharmaceutical products.

• Includes crates, pallets, and shrink wraps.

• Protects products from mechanical damage during shipping.

• Ensures safe handling and efficient distribution.

3. Emulsifying Agents

• Substances that stabilize emulsions by reducing surface tension between


oil and water phases.

• Examples:

o Natural: Acacia, Lecithin

o Synthetic: Tweens (Polysorbates), Spans (Sorbitan esters)

o Finely Divided Solids: Bentonite, Magnesium hydroxide

4. Polyethylene Glycol (PEG)

• A water-soluble polymer used as a solvent, plasticizer, and base in


pharmaceutical formulations.

• Acts as an osmotic agent in laxatives.

• Enhances drug solubility and stability.

• Commonly used in ointments, suppositories, and parenteral


preparations.

5. Types of Problems in Optimization

• Linear vs. Non-linear Optimization – Based on the mathematical nature


of the problem.
• Single-objective vs. Multi-objective Optimization – Whether optimizing
one or multiple goals.

• Constrained vs. Unconstrained Optimization – Presence of restrictions


in the solution space.

• Deterministic vs. Stochastic Optimization – Whether variables are


known or have uncertainty.

6. Elements of Quality by Design (QbD)

• Target Product Profile (TPP) – Defines desired product characteristics.

• Critical Quality Attributes (CQA) – Properties affecting drug quality.

• Risk Assessment – Identifying and mitigating process risks.

• Design of Experiment (DoE) – Using statistical tools for process


optimization.

• Control Strategy – Ensuring consistent product quality.

7. Classification of Non-Ionic Surfactants

• Polyoxyethylene-based: Polysorbates (Tween 20, Tween 80).

• Sorbitan esters: Span 60, Span 80.

• Fatty alcohol ethoxylates: Cetomacrogol, Brij series.

• Amphiphilic block copolymers: Pluronics (Poloxamers).

8. Systemic Optimization Techniques

• Gradient Descent – Used for machine learning and numerical


optimization.

• Genetic Algorithms – Inspired by natural selection.

• Simulated Annealing – Mimics metal cooling processes for global


optimization.

• Response Surface Methodology (RSM) – Analyzes the effects of multiple


variables.

9. Applications of Optimization

• Pharmaceutical Formulation – Optimizing drug release profiles.

• Process Engineering – Reducing manufacturing costs and improving


efficiency.
• Clinical Trials – Optimizing dosage and treatment strategies.

• Supply Chain Management – Streamlining logistics and distribution.

10. Pharmaceutical Excipients

• Inactive substances added to drug formulations to aid processing and


enhance drug delivery.

• Types:

o Binders: Starch, Polyvinylpyrrolidone (PVP).

o Disintegrants: Croscarmellose sodium, Sodium starch glycolate.

o Lubricants: Magnesium stearate, Talc.

o Preservatives: Benzalkonium chloride, Parabens.

You might also like